Amy L. Schofield
Impact in
-
- Drug-Induced Hepatotoxicity and Protection
-
- MicroRNA in disease regulation
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 4
-
- MicroRNA in disease regulation 2
- NF-κB Signaling Pathways 2
- Co-authors
- Clive Edwards (1 shared paper)David Garth Fernig (1 shared paper)David S. Martin (2 shared papers)Timothy Robert Rudd (1 shared paper)Christopher E. Goldring (3 shared papers)Rachel Williams (3 shared papers)P. Weightman (3 shared papers)B. Kevin Park (2 shared papers)
- Journals
- Hepatology (2 papers)Journal of Physics D Applied Physics (2 papers)Archives of Toxicology (2 papers)Biosensors and Bioelectronics (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Amy L. Schofield
12 papers receiving 306 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 34
- Cancer Research 43
- Hepatology 22
- Molecular Biology 136
- Biotechnology 12
Countries citing papers authored by Amy L. Schofield
This map shows the geographic impact of Amy L. Schofield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Schofield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Schofield more than expected).
Fields of papers citing papers by Amy L. Schofield
This network shows the impact of papers produced by Amy L. Schofield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Schofield. The network helps show where Amy L. Schofield may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy L. Schofield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 65 | |
| 2 | 2012 | 45 | |
| 3 | 2021 | 45 | |
| 4 | 2022 | 42 | |
| 5 | 2019 | 39 | |
| 6 | 2018 | 28 | |
| 7 | 2018 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2010 | 8 | |
| 10 | 2011 | 3 | |
| 11 | 2024 | 3 | |
| 12 | The status of the ALICE Accelerator R&D Facility at STFC Daresbury Laboratory | 2011 | 1 |
| 13 | Model-based identification of TNF alpha-induced IKK beta-mediated and I kappa B alpha-mediated regulation of NF kappa B signal transduction as a tool to quantify the impact of drug-induced liver injury compounds | 2018 | 1 |
About Amy L. Schofield
Amy L. Schofield is a scholar working on Pharmacology, Cancer Research, Molecular Biology, Periodontics and Hepatology, having authored 13 papers that have together received 316 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (2 papers), NF-κB Signaling Pathways (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Particle Detector Development and Performance (1 paper), Plant Genetic and Mutation Studies (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Pharmacology (34 citations), Cancer Research (43 citations), Hepatology (22 citations), Molecular Biology (136 citations) and Biotechnology (12 citations). Amy L. Schofield has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Clive Edwards, David Garth Fernig, David S. Martin, Timothy Robert Rudd, Christopher E. Goldring, Rachel Williams, P. Weightman, B. Kevin Park, James K Jones and Peter Howard Williams. Their work appears in journals such as Hepatology, Journal of Physics D Applied Physics, Archives of Toxicology, Biosensors and Bioelectronics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.